Motion Sickness (MS)
Conditions
Interventions
Mobile Phone Anti-Sickness Measures Group:Mobile Phone Anti-Sickness Measures
Vehicle Anti-Sickness Measures Group:Vehicle Anti-Sickness Measures
Joint Mobile Phone and Vehicle Anti-Sickness Measures Group:Joint Mobile Phone and Vehicle Anti-Sickness Measures
Sponsors
Bejing Tongren Hospital, Capital Medical Uniersity
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Age Requirement: Adults aged 18-65 years old, regardless of gender. 2.Have a clear history of motion sickness, have experienced symptoms of motion sickness at least within the past year, and have scored at a moderate level or above using a standardised motion sickness susceptibility questionnaire (e.g. Motion Sickness Susceptibility Questionnaire). 3.Health status: Good general health, no serious chronic diseases; no known cardiovascular, respiratory, neurological or psychiatric diseases, and no health problems that may affect physiological parameters or interfere with experimental results. 4.Drug use: not using any anti-motion sickness drugs or drugs affecting vestibular function within 4 weeks before the experiment, not relying on any drugs that may affect physiological indicators (e.g., drugs affecting blood pressure, heart rate). 5.Physiological status: blood pressure, heart rate, body temperature and other basic physiological indicators within the normal range. 6.Vision and hearing: normal or corrected vision (contact lenses may be worn); normal hearing. 7.Vestibular function: no known vestibular dysfunction. 8.PREGNANCY STATUS: Female subjects must not be pregnant or breastfeeding. 9.Ability to participate in the experiment: ability to understand and follow experimental instructions, ability to accurately report subjective feelings. 10.Time Commitment: willingness and ability to participate in the complete experimental procedure, including necessary follow-up visits. 11.Technological adaptability: familiarity with basic smartphone operation (for the mobile phone anti-dizziness application test). 12.Informed consent: willing to sign an informed consent form and understand the possible discomfort and risks associated with the experiment.
Exclusion criteria
Exclusion criteria: 1.uffering from any chronic disease that may affect physiological parameters or interfere with experimental results, e.g., cardiovascular disease (e.g., hypertension, arrhythmia, coronary artery disease); respiratory disease (e.g., asthma, COPD); neurological disease (e.g., epilepsy, multiple sclerosis); psychiatric disease (e.g., anxiety, depression); endocrine disease (e.g., diabetes mellitus, abnormalities of the thyroid gland function); history of vestibular dysfunction or history of balance problems; history of migraine headaches (which may affect susceptibility to motion sickness). 2.Use of medications that may affect the results of the test, e.g., antimotion sickness medications; medications affecting the central nervous system (e.g., sedatives, antidepressants); medications affecting the cardiovascular system (e.g., beta blockers); medications affecting vestibular function; and a history of drug or alcohol dependence. 3.Special physiological conditions: pregnant or breastfeeding women; recent (within 3 months) major surgery; history of syncope. 4.Audiovisual: severe uncorrected vision problems; colour blindness or colour deficiency (which may affect response to visual stimuli); severe hearing loss. 5.Experiment-related: individuals unable to understand or follow experimental instructions; allergies to any equipment or materials used in the experiment; claustrophobic individuals (may not tolerate simulated environments). 6.Prior Participation: Participation in other clinical trials within the past 1 month that may affect the results of this study; have participated in similar motion sickness studies and may be overly familiar with the experimental procedures. 7.Occupational Relevance: Professional drivers or those who regularly drive long distances (may have an unusual adaptation to motion sickness); professional athletes or balance training professionals (may have atypical vestibular function). 8.Age-related: individuals under the age of 18 or over the age of 65. 9.pecial circumstances: Individuals with a history of severe motion sickness (symptoms are too severe and may not be able to complete the entire experimental procedure); Individuals who have an extreme fear or anxiety response to the simulated exercise environment. 10.Device compatibility: medical devices implanted in the body that may interfere with the experimental equipment (e.g., pacemakers). 11.Data Collection Impairment: Abnormal skin conditions that may interfere with the collection of physiological data (e.g., severe eczema or dermatitis); individuals who are unable to maintain prolonged periods of sedentary sitting or to maintain a specific posture. 12.Legal: Individuals unable to provide valid informed consent; individuals under legal guardianship. 13.Any other condition that, in the opinion of the investigator, makes participation in this trial inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| heart rate;body temperature;blood oxygen saturation;respiratory rate;picoelectricity;eye tremor;Subjective questionnaires;cholesterol; | — |
Countries
China
Contacts
Public ContactLei Tian
Bejing Tongren Hospital, Capital Medical Uniersity
Outcome results
None listed